LPL Financial LLC Grows Stock Position in Kenvue Inc. (NYSE:KVUE)

LPL Financial LLC raised its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 4.9% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,064,405 shares of the company's stock after purchasing an additional 96,030 shares during the period. LPL Financial LLC owned 0.11% of Kenvue worth $44,075,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. KLP Kapitalforvaltning AS purchased a new position in shares of Kenvue in the fourth quarter worth about $14,779,000. Sei Investments Co. raised its holdings in Kenvue by 1.0% in the 4th quarter. Sei Investments Co. now owns 2,207,060 shares of the company's stock valued at $47,121,000 after acquiring an additional 20,802 shares during the last quarter. Mizuho Securities USA LLC lifted its stake in Kenvue by 46.3% in the 4th quarter. Mizuho Securities USA LLC now owns 181,712 shares of the company's stock worth $3,880,000 after purchasing an additional 57,524 shares in the last quarter. Virtu Financial LLC purchased a new position in Kenvue in the 4th quarter worth approximately $1,269,000. Finally, Millstone Evans Group LLC acquired a new position in shares of Kenvue during the 4th quarter worth approximately $565,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on KVUE. Deutsche Bank Aktiengesellschaft downgraded Kenvue from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. Barclays lifted their price target on Kenvue from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, March 27th. Piper Sandler upped their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a report on Monday, February 24th. Citigroup reduced their target price on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research note on Wednesday, January 15th. Finally, Evercore ISI started coverage on shares of Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 price target for the company. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $24.00.

Remove Ads

Kenvue Trading Down 0.0 %

NYSE KVUE traded down $0.01 on Wednesday, reaching $23.87. The stock had a trading volume of 14,091,300 shares, compared to its average volume of 16,741,428. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The stock has a fifty day moving average price of $22.50 and a two-hundred day moving average price of $22.47. The firm has a market capitalization of $45.62 billion, a price-to-earnings ratio of 45.04, a P/E/G ratio of 2.62 and a beta of 1.25. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date was Wednesday, February 12th. Kenvue's dividend payout ratio (DPR) is currently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.